Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction survey

R Ravindran, L Szadkowski, LE Lovblom… - PLOS Digital …, 2023 - journals.plos.org
The Covid-19 pandemic required many clinical trials to adopt a decentralized framework to
continue research activities during lock down restrictions. The STOPCoV study was designed …

Safety and efficacy of preventative COVID vaccines: the StopCoV study

…, K Colwill, P Rochon, M Brudno, R Ravindran… - medRxiv, 2022 - medrxiv.org
Background To partially immunize more persons against COVID-19 during a time of limited
vaccine availability, Canadian public health officials recommended extending the vaccine …

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination

S Walmsley, M Nabipoor, LE Lovblom, R Ravindran… - Vaccines, 2023 - mdpi.com
The initial two-dose vaccine series and subsequent booster vaccine doses have been
effective in modulating SARS-CoV-2 disease severity and death but do not completely prevent …

COVID-19 breakthrough infections in vaccinated participants of the Safety and Efficacy of Preventative COVID Vaccines sub-study

S Walmsley, R Ravindran, R Clarke… - Official Journal of …, 2022 - jammi.utpjournals.press
BACKGROUND: The rate of breakthrough infection in vaccinated Ontarians during the
Omicron wave is unknown. METHODS: Active participants of the Safety and Efficacy of …

Prospective Decentralized Study Evaluating Antibody Responses to COVID-19 Vaccines in Community Dwelling Adults to 48 Weeks Post Primary Vaccine Series

…, K Colwill, P Rochon, M Brudno, R Ravindran… - 2023 - papers.ssrn.com
Older persons were prioritized for COVID-19 vaccination. It was anticipated antibody
responses would wane more rapidly in older individuals but there is limited long term data. We …

Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study (preprint)

…, K Colwill, P Rochon, M Brudno, R Ravindran… - 2022 - pesquisa.bvsalud.org
Background: To partially immunize more persons against COVID-19 during a time of limited
vaccine availability, Canadian public health officials recommended extending the vaccine …

[PDF][PDF] on behalf of the STOPCoV Team. Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination. Vaccines 2024, 12, 36

S Walmsley, M Nabipoor, LE Lovblom, R Ravindran… - 2023 - stopcov.ca
The initial two-dose vaccine series and subsequent booster vaccine doses have been
effective in modulating SARS-CoV-2 disease severity and death but do not completely prevent …

[PDF][PDF] Feasibility and Acceptability of Self-Collected Dried Blood Spots for SARS-CoV-2 Vaccine Response in Community-Dwelling Elderly: A Large Decentralized …

…, C Valdez, E Lovblum, R Ravindran… - J. Community Med …, 2023 - stopcov.ca
Background: The STOP-CoV study is an ongoing longitudinal decentralized cohort study
assessing the safety and efficacy of the SARS-CoV-2 vaccine. There are limited longitudinal …

Bacteremia antibiotic length actually needed for clinical effectiveness (BALANCE) randomised clinical trial: study protocol

N Daneman, AH Rishu, RL Pinto, YM Arabi, DJ Cook… - BMJ open, 2020 - bmjopen.bmj.com
Introduction Bloodstream infections are a leading cause of mortality and morbidity; the duration
of treatment for these infections is understudied. Methods and analysis We will conduct …

A pilot randomized controlled trial of 7 versus 14 days of antibiotic treatment for bloodstream infection on non-intensive care versus intensive care wards

N Daneman, AH Rishu, R Pinto, Y Arabi… - Trials, 2020 - Springer
… and Rizani Ravindran. We also like to acknowledge the crucial contributions of Lisa Buckingham
and Nicole Zytaruk at the CLARITY methods centre in helping to develop the electronic …